Publications

BibTex format

@inproceedings{Popat:2022,
author = {Popat, S and Kim, HR and Ahn, M-J and Yang, J and Han, J-Y and Hochmair, M and Lee, KH and Delmonte, A and Garcia, Campelo M and Kim, D-W and Griesinger, F and Felip, E and Califano, R and Spira, A and Gettinger, S and Tiseo, M and Lin, H and Liu, Y and Vranceanu, F and Camidge, D},
pages = {S27--S28},
publisher = {ELSEVIER IRELAND LTD},
title = {Brigatinib vs crizotinib in ALK TKI-naive ALK plus NSCLC: final results from ALTA-1L},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000774314500061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2022}
}

Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Popat,S
AU  - Kim,HR
AU  - Ahn,M-J
AU  - Yang,J
AU  - Han,J-Y
AU  - Hochmair,M
AU  - Lee,KH
AU  - Delmonte,A
AU  - Garcia,Campelo M
AU  - Kim,D-W
AU  - Griesinger,F
AU  - Felip,E
AU  - Califano,R
AU  - Spira,A
AU  - Gettinger,S
AU  - Tiseo,M
AU  - Lin,H
AU  - Liu,Y
AU  - Vranceanu,F
AU  - Camidge,D
EP  - 28
PB  - ELSEVIER IRELAND LTD
PY  - 2022///
SN  - 0169-5002
SP  - 27
TI  - Brigatinib vs crizotinib in ALK TKI-naive ALK plus NSCLC: final results from ALTA-1L
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000774314500061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -

Download

DrSanjayPopat

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)